ALAS2 | Aminolevulinate, delta-, synthase 2 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
ALDH18A1 | Aldehyde dehydrogenase 18 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
ALDH1A1 | Aldehyde dehydrogenase 1 family, member A1 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ALDH1A2 | Aldehyde dehydrogenase 1 family, member A2 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
ALDH1A3 | Aldehyde dehydrogenase 1 family, member A3 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
ALDH1B1 | Aldehyde dehydrogenase 1 family, member B1 | Enzymes Mitochondrial proteins Predicted intracellular proteins
| | | | | Expressed in all |
ALDH1L1 | Aldehyde dehydrogenase 1 family, member L1 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
ALDH1L2 | Aldehyde dehydrogenase 1 family, member L2 | Enzymes Predicted intracellular proteins
| | | | | Mixed |
ALDH2 | Aldehyde dehydrogenase 2 family (mitochondrial) | Cancer-related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ALDH3A1 | Aldehyde dehydrogenase 3 family, member A1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
ALDH3A2 | Aldehyde dehydrogenase 3 family, member A2 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ALDH3B1 | Aldehyde dehydrogenase 3 family, member B1 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
ALDH3B2 | Aldehyde dehydrogenase 3 family, member B2 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ALDH4A1 | Aldehyde dehydrogenase 4 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
ALDH5A1 | Aldehyde dehydrogenase 5 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
ALDH6A1 | Aldehyde dehydrogenase 6 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
ALDH7A1 | Aldehyde dehydrogenase 7 family, member A1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Mixed |
ALDH9A1 | Aldehyde dehydrogenase 9 family, member A1 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
ALDOA | Aldolase A, fructose-bisphosphate | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
ALDOB | Aldolase B, fructose-bisphosphate | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
ALDOC | Aldolase C, fructose-bisphosphate | Cancer-related genes Candidate cardiovascular disease genes Cytoskeleton related proteins Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
ALG1 | ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ALG10 | ALG10, alpha-1,2-glucosyltransferase | Enzymes Predicted membrane proteins
| | | | | Mixed |
ALG10B | ALG10B, alpha-1,2-glucosyltransferase | Enzymes Predicted membrane proteins
| | | | | Mixed |
ALG11 | ALG11, alpha-1,2-mannosyltransferase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ALG12 | ALG12, alpha-1,6-mannosyltransferase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
ALG13 | ALG13, UDP-N-acetylglucosaminyltransferase subunit | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
ALG2 | ALG2, alpha-1,3/1,6-mannosyltransferase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ALG3 | ALG3, alpha-1,3- mannosyltransferase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
ALG5 | ALG5, dolichyl-phosphate beta-glucosyltransferase | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ALG6 | ALG6, alpha-1,3-glucosyltransferase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
ALG8 | ALG8, alpha-1,3-glucosyltransferase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
ALG9 | ALG9, alpha-1,2-mannosyltransferase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ALK | Anaplastic lymphoma receptor tyrosine kinase | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ALKBH1 | AlkB, alkylation repair homolog 1 (E. coli) | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
ALKBH2 | AlkB, alkylation repair homolog 2 (E. coli) | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
ALKBH8 | AlkB, alkylation repair homolog 8 (E. coli) | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
ALLC | Allantoicase | Enzymes Predicted intracellular proteins
| | | | | Tissue enriched |
ALOX12 | Arachidonate 12-lipoxygenase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
ALOX15 | Arachidonate 15-lipoxygenase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
ALOX15B | Arachidonate 15-lipoxygenase, type B | Cytoskeleton related proteins Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
ALOX5 | Arachidonate 5-lipoxygenase | Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Mixed |
ALOXE3 | Arachidonate lipoxygenase 3 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enriched |
ALPI | Alkaline phosphatase, intestinal | Enzymes Predicted secreted proteins
| | | | | Group enriched |
ALPK1 | Alpha-kinase 1 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
ALPK2 | Alpha-kinase 2 | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
ALPK3 | Alpha-kinase 3 | Enzymes Predicted intracellular proteins
| | | | | Group enriched |
ALPL | Alkaline phosphatase, liver/bone/kidney | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ALPP | Alkaline phosphatase, placental | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ALPPL2 | Alkaline phosphatase, placental-like 2 | Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |